China Resources Double-Crane Pharmaceutical Co Ltd (600062) — Cash Flow Reinvestment Rate
China Resources Double-Crane Pharmaceutical Co Ltd (600062) has a Cash Flow Reinvestment Rate of 0.39x as of September 2025, reinvesting CN¥192.28 Million (capex CN¥192.28 Million ) from operating cash flow of CN¥487.90 Million. Explore how much does China Resources Double-Crane Pharmaceuti reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China Resources Double-Crane Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2024)
Historical reinvestment intensity for China Resources Double-Crane Pharmaceutical Co Ltd across 26 annual periods. Also explore total assets of China Resources Double-Crane Pharmaceuti for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for China Resources Double-Crane Pharmaceutical Co Ltd (1999–2024)
Year-by-year capital reinvestment analysis for China Resources Double-Crane Pharmaceutical Co Ltd. For live market cap and broader valuation context, see China Resources Double-Crane Pharmaceuti (600062) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.50x | CN¥905.94 Million | CN¥1.83 Billion | CN¥637.50 Million | ▼ -37.0% |
| 2023 | 0.79x | CN¥1.30 Billion | CN¥1.65 Billion | CN¥614.31 Million | ▼ -48.0% |
| 2022 | 1.51x | CN¥2.03 Billion | CN¥1.34 Billion | CN¥525.53 Million | ▲ +203.6% |
| 2021 | 0.50x | CN¥669.03 Million | CN¥1.34 Billion | CN¥491.67 Million | ▲ +34.3% |
| 2020 | 0.37x | CN¥505.32 Million | CN¥1.36 Billion | CN¥348.09 Million | ▼ -46.7% |
| 2019 | 0.70x | CN¥1.00 Billion | CN¥1.44 Billion | CN¥241.65 Million | ▲ +71.0% |
| 2018 | 0.41x | CN¥598.40 Million | CN¥1.47 Billion | CN¥228.69 Million | ▼ -18.4% |
| 2017 | 0.50x | CN¥592.58 Million | CN¥1.19 Billion | CN¥154.82 Million | ▲ +40.8% |
| 2016 | 0.35x | CN¥273.34 Million | CN¥771.25 Million | CN¥110.04 Million | ▼ -4.8% |
| 2015 | 0.37x | CN¥260.99 Million | CN¥701.35 Million | CN¥168.49 Million | ▲ +87.8% |
| 2014 | 0.20x | CN¥142.38 Million | CN¥718.38 Million | CN¥142.38 Million | ▼ -50.3% |
| 2013 | 0.40x | CN¥217.68 Million | CN¥546.24 Million | CN¥217.68 Million | ▼ -28.9% |
| 2012 | 0.56x | CN¥221.89 Million | CN¥396.05 Million | CN¥221.89 Million | ▼ -15.4% |
| 2011 | 0.66x | CN¥338.78 Million | CN¥511.53 Million | CN¥338.78 Million | ▼ -8.8% |
| 2010 | 0.73x | CN¥370.18 Million | CN¥509.67 Million | CN¥370.18 Million | ▼ -12.9% |
| 2009 | 0.83x | CN¥285.16 Million | CN¥342.01 Million | CN¥285.16 Million | ▼ -10.6% |
| 2008 | 0.93x | CN¥309.20 Million | CN¥331.71 Million | CN¥309.20 Million | ▲ +61.2% |
| 2007 | 0.58x | CN¥136.17 Million | CN¥235.46 Million | CN¥136.17 Million | ▲ +2.3% |
| 2006 | 0.57x | CN¥171.66 Million | CN¥303.71 Million | CN¥171.66 Million | ▼ -37.9% |
| 2005 | 0.91x | CN¥127.13 Million | CN¥139.78 Million | CN¥127.13 Million | ▲ +109.7% |
| 2004 | 0.43x | CN¥196.84 Million | CN¥453.72 Million | CN¥196.84 Million | ▼ -82.8% |
| 2003 | 2.52x | CN¥375.98 Million | CN¥148.94 Million | CN¥375.98 Million | ▲ +40.9% |
| 2002 | 1.79x | CN¥251.99 Million | CN¥140.63 Million | CN¥251.99 Million | ▲ +43.9% |
| 2001 | 1.25x | CN¥175.58 Million | CN¥141.01 Million | CN¥175.58 Million | ▲ +147.8% |
| 2000 | 0.50x | CN¥86.83 Million | CN¥172.81 Million | CN¥86.83 Million | ▼ -5.4% |
| 1999 | 0.53x | CN¥69.86 Million | CN¥131.54 Million | CN¥69.86 Million | — |